SHANGHAI HAIKANG PHARMACEUTICAL

The company has two business segments: research and development of biological new drugs and research and development of plant extracts. The company has strong research and development strength, and the introduction of several professors and experts from the Institute of Oncology of the Chinese Academy of Medical Sciences has laid a solid foundation for the company's high growth and core competitiveness.